Orphapacket:
  ORPHApacketId: '654'
  creationDate: '2020-12-03 15:53:15'
  version: 1.3.6 / 4.1.7 [2020-04-17] (orientdb version)
  copyright: Orphanet (c) 2020
  ORPHAcode: '654'
  Label: Nephroblastoma
  PURL: http://www.orpha.net/ORDO/Orphanet_654
  DisorderType:
    value: Disease
    PURL: http://www.orpha.net/ORDO/Orphanet_377788
  Synonyms:
  - Synonym: Renal embryonic tumor
  - Synonym: Wilms tumor
  ExternalReferences:
  - ExternalReference:
      Source: OMIM
      Reference: '194070'
      DisorderMappingRelation: BTNT (ORPHA code's Broader Term maps to a Narrower
        Term)
  - ExternalReference:
      Source: OMIM
      Reference: '194071'
      DisorderMappingRelation: BTNT (ORPHA code's Broader Term maps to a Narrower
        Term)
  - ExternalReference:
      Source: OMIM
      Reference: '194090'
      DisorderMappingRelation: BTNT (ORPHA code's Broader Term maps to a Narrower
        Term)
  - ExternalReference:
      Source: OMIM
      Reference: '601363'
      DisorderMappingRelation: BTNT (ORPHA code's Broader Term maps to a Narrower
        Term)
  - ExternalReference:
      Source: OMIM
      Reference: '601583'
      DisorderMappingRelation: BTNT (ORPHA code's Broader Term maps to a Narrower
        Term)
  - ExternalReference:
      Source: OMIM
      Reference: '616806'
      DisorderMappingRelation: BTNT (ORPHA code's Broader Term maps to a Narrower
        Term)
  TextSection:
    TextSectionType: Definition
    Contents: A rare malignant renal tumor typically affecting the pediatric population
      characterized by an abnormal proliferation of cells that resemble the kidney
      cells of an embryo (metanephroma) leading to the term embryonal tumor.
  Genes:
  - Gene:
      Symbol: BRCA2
      Name: BRCA2 DNA repair associated
      ExternalReferences: []
  - Gene:
      Symbol: GPC3
      Name: glypican 3
      ExternalReferences: []
  - Gene:
      Symbol: TRIM28
      Name: tripartite motif containing 28
      ExternalReferences: []
  - Gene:
      Symbol: TRIM28
      Name: tripartite motif containing 28
      ExternalReferences: []
  - Gene:
      Symbol: REST
      Name: RE1 silencing transcription factor
      ExternalReferences: []
  - Gene:
      Symbol: TRIP13
      Name: thyroid hormone receptor interactor 13
      ExternalReferences: []
  - Gene:
      Symbol: POU6F2
      Name: POU class 6 homeobox 2
      ExternalReferences: []
  - Gene:
      Symbol: WT1
      Name: WT1 transcription factor
      ExternalReferences: []
  - Gene:
      Symbol: WT1
      Name: WT1 transcription factor
      ExternalReferences: []
  - Gene:
      Symbol: H19
      Name: H19 imprinted maternally expressed transcript
      ExternalReferences: []
  - Gene:
      Symbol: DIS3L2
      Name: DIS3 like 3'-5' exoribonuclease 2
      ExternalReferences: []
  Parents:
  - Parent:
    - ORPHAcode: '93619'
      Label: Rare renal tumor
  - Parent:
    - ORPHAcode: '183595'
      Label: Genetic renal tumor
  - Parent:
    - ORPHAcode: '506213'
      Label: Rare disorder potentially indicated for kidney transplant
  Phenotypes:
  - Phenotype:
      HPOId: HP:0000526
      HPOTerm: Aniridia
      HPOFrequency: Occasional (29-5%)
  - Phenotype:
      HPOId: HP:0000790
      HPOTerm: Hematuria
      HPOFrequency: Occasional (29-5%)
  - Phenotype:
      HPOId: HP:0000822
      HPOTerm: Hypertension
      HPOFrequency: Occasional (29-5%)
  - Phenotype:
      HPOId: HP:0001824
      HPOTerm: Weight loss
      HPOFrequency: Occasional (29-5%)
  - Phenotype:
      HPOId: HP:0001945
      HPOTerm: Fever
      HPOFrequency: Occasional (29-5%)
  - Phenotype:
      HPOId: HP:0002027
      HPOTerm: Abdominal pain
      HPOFrequency: Very frequent (99-80%)
  - Phenotype:
      HPOId: HP:0002664
      HPOTerm: Neoplasm
      HPOFrequency: Very frequent (99-80%)
  - Phenotype:
      HPOId: HP:0002667
      HPOTerm: Nephroblastoma
      HPOFrequency: Very frequent (99-80%)
  - Phenotype:
      HPOId: HP:0002716
      HPOTerm: Lymphadenopathy
      HPOFrequency: Occasional (29-5%)
  - Phenotype:
      HPOId: HP:0002896
      HPOTerm: Neoplasm of the liver
      HPOFrequency: Occasional (29-5%)
  - Phenotype:
      HPOId: HP:0100526
      HPOTerm: Neoplasm of the lung
      HPOFrequency: Occasional (29-5%)
  Prevalences:
  - Prevalence:
      Source: 22357215[PMID]_RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 1 000 000
      ValMoy: no data
      PrevalenceGeographic: Europe
  - Prevalence:
      Source: 22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Point prevalence
      PrevalenceQualification: Class only
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: Europe
  - Prevalence:
      Source: 22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Lifetime Prevalence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: Europe
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 1 000 000
      ValMoy: no data
      PrevalenceGeographic: United Kingdom
  - Prevalence:
      Source: '[EXPERT]'
      PrevalenceType: Prevalence at birth
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-5 / 10 000
      ValMoy: no data
      PrevalenceGeographic: Europe
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: <1 / 1 000 000
      ValMoy: no data
      PrevalenceGeographic: Bulgaria
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: <1 / 1 000 000
      ValMoy: no data
      PrevalenceGeographic: Czech Republic
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: <1 / 1 000 000
      ValMoy: no data
      PrevalenceGeographic: Germany
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: <1 / 1 000 000
      ValMoy: no data
      PrevalenceGeographic: Iceland
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: <1 / 1 000 000
      ValMoy: no data
      PrevalenceGeographic: Latvia
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: <1 / 1 000 000
      ValMoy: no data
      PrevalenceGeographic: Portugal
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 1 000 000
      ValMoy: no data
      PrevalenceGeographic: Austria
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 1 000 000
      ValMoy: no data
      PrevalenceGeographic: Belgium
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 1 000 000
      ValMoy: no data
      PrevalenceGeographic: Croatia
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 1 000 000
      ValMoy: no data
      PrevalenceGeographic: Estonia
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 1 000 000
      ValMoy: no data
      PrevalenceGeographic: Finland
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 1 000 000
      ValMoy: no data
      PrevalenceGeographic: Ireland
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 1 000 000
      ValMoy: no data
      PrevalenceGeographic: Italy
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 1 000 000
      ValMoy: no data
      PrevalenceGeographic: Lithuania
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 1 000 000
      ValMoy: no data
      PrevalenceGeographic: Malta
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 1 000 000
      ValMoy: no data
      PrevalenceGeographic: Norway
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 1 000 000
      ValMoy: no data
      PrevalenceGeographic: Poland
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 1 000 000
      ValMoy: no data
      PrevalenceGeographic: Slovakia
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 1 000 000
      ValMoy: no data
      PrevalenceGeographic: Slovenia
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 1 000 000
      ValMoy: no data
      PrevalenceGeographic: Spain
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 1 000 000
      ValMoy: no data
      PrevalenceGeographic: Switzerland
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 1 000 000
      ValMoy: no data
      PrevalenceGeographic: Netherlands
  AverageAgeOfOnsets:
    AverageAgeOfOnset:
    - value: Childhood
  AverageAgeOfDeaths:
    AverageAgeOfDeath:
    - value: any age
  TypeOfInheritances:
  - TypeOfInheritance:
      value: Autosomal dominant
  - TypeOfInheritance:
      value: Not applicable
